NervGen Pharma Reports 2024 Year-End Financial Results and Provides Business Updates

Go back to NervGen Pharma Reports 2024 Year-End Financial Results and Provides Business Updates
(AMEX: NGENF) Delayed: 5.84 --0 (-0%)
Previous Close $5.84    52 Week High $ 
Open $5.84    52 Week Low $ 
Day High $5.84    P/E N/A 
Day Low $5.84    EPS $ 
Volume 28,675